Analytical Quality by Design, Life Cycle Management, and Method Control.
AQbD
Analytical target profile (ATP)
Life cycle management
Method validation
Quality by design (QbD)
Journal
The AAPS journal
ISSN: 1550-7416
Titre abrégé: AAPS J
Pays: United States
ID NLM: 101223209
Informations de publication
Date de publication:
11 02 2022
11 02 2022
Historique:
received:
13
11
2021
accepted:
19
01
2022
entrez:
12
2
2022
pubmed:
13
2
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Analytical methods are utilized throughout the biopharmaceutical and vaccines industries to conduct research and development, and to help control manufacturing inputs and outputs. These analytical methods should continuously provide quality data to support decisions while managing the remaining of risk and uncertainty. Analytical quality by design (AQbD) can provide a systematic framework to achieve a continuously validated, robust assay as well as life cycle management. AQbD is rooted in ICH guidelines Q8 and Q9 that were translated to the analytical space through several white papers as well as upcoming USP 1220 and ICH Q14. In this white paper, we expand on the previously published concepts of AQbD by providing additional context for implementation in relation to ICH Q14. Using illustrative examples, we describe the AQbD workflow, its relation to traditional approaches, and potential pathways for ongoing, real-time verification. We will also discuss challenges with respect to implementation and regulatory strategies.
Identifiants
pubmed: 35149913
doi: 10.1208/s12248-022-00685-2
pii: 10.1208/s12248-022-00685-2
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
34Informations de copyright
© 2022. The Author(s).
Références
Schweitzer M, Pohl M, Hanna-Brown M, Nethercote P, Borman P, Hansen G, et al. Implications and opportunities of applying QbD principles to analytical measurements. Pharm Technol. 2010;34:52–9.
International Conference for Harmonization. ICH Q14: analytical procedure development and revision of Q2(R1) analytical validation. In: ICH Final Concept Pap [Internet]; 2018. Available from: https://database.ich.org/sites/default/files/Q2R2-Q14_EWG_Concept_Paper.pdf .
International Conference for Harmonization. Quality risk management Q9. In: ICH Harmon. Guidel: Tripart; 2005. p. 1–23.
International Conference for Harmonization. Pharmaceutical quality system (Q10). 2008.
International Conference for Harmonization. Pharmaceutical Development Q8(R2): ICH Harmon Tripart Guidel; 2009. p. 1–24.
Junker B, Zablackis E, Verch T, Schofield T, Douette P. Quality-by-design: as related to analytical concepts, control and qualification. In: Nunnally BK, Turula VE, Sitrin RD, editors. Vaccine Anal Strateg Princ Control [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. p. 479–520. https://doi.org/10.1007/978-3-662-45024-6_12 .
doi: 10.1007/978-3-662-45024-6_12
Barnett K, McGregor PL, Martin GP, Blond DJ, Weitzel J, Ermer J, et al. Analytical target profile: structure and application throughout the analytical lifecycle. Pharmacopeial Forum. 2016;42.
Jackson P, Borman P, Campa C, Chatfield M, Godfrey M, Hamilton P, Hoyer W, Norelli F, Orr R, Schofield T. Using the analytical target profile to drive the analytical method lifecycle. Anal Chem [Internet]. 2019/02/08. United States. 2019;91:2577–85 Available from: https://pubmed.ncbi.nlm.nih.gov/30624912 .
Parr MK, Schmidt AH. Life cycle management of analytical methods. J. Pharm. Biomed. Anal. Elsevier B.V. 2018:506–17.
United States Pharmacopeia. <1220> Analytical procedure Lifecycle - Draft. USP NF [Internet]. 2022; Available from: https://www.uspnf.com/notice-gc-1220-prepost-20210924
Burgess C. Evaluating risk-based specifications for pharmaceuticals: the author discusses the purpose of analysis and testing and the implications for specifications and their underlying statistical distribution. Pharm Technol. 2013.
Burgess C. Using the guard band to determine a risk-based specification: how to calculate and apply a guard band. Pharm Technol. 2014.
Martin GP, Barnett KL, Burgess C, Curry PD, Ermer J, Gratzl GS, et al. Lifecycle management of analytical procedures: method development, procedure performance qualification, and procedure performance verification. Pharmacopeial Forum. 2013.
Voltae Sousa L, Gonçalves R, Menezes JC, Ramos A. Analytical method lifecycle management in pharmaceutical industry: a review. AAPS PharmSciTech [Internet]. 2021;22:128 Available from: 10.1208/s12249-021-01960-9.
doi: 10.1208/s12249-021-01960-9
Argentine M, Barnett K, Chatfield M, Hewitt E, Jackson P, Karmarkar S, et al. Evaluating progress in analytical quality by design. Pharm Technol. 2017;41:52–9.
International Conference for Harmonization. Final concept paper Q12: technical and regulatory considerations for pharmaceutical product lifecycle management. Int Conf Harmon. 2014.
International Conference for Harmonization. Validation of analytical procedures Q2(R1). Fed Regist. 1997;62(96):27463–7.
International Conference for Harmonization. Technical and regulatory considerations for pharmaceutical product life cycle management. ICH Harmon Tripart Guidel [Internet]. 2019:1–31 Available from: https://database.ich.org/sites/default/files/Q12_Guideline_Step4_2019_1119.pdf .
Ermer J, Aguiar D, Boden A, Ding B, Obeng D, Rose M, et al. Lifecycle management in pharmaceutical analysis: how to establish an efficient and relevant continued performance monitoring program. J Pharm Biomed Anal [Internet]. 2020;181:113051 https://www.sciencedirect.com/science/article/pii/S0731708519319089 .
doi: 10.1016/j.jpba.2019.113051
Yarovoi H, Frey T, Bouaraphan S, Retzlaff M, Verch T. Quality by design for a vaccine release immunoassay: a case study. Bioanalysis [Internet]. 2013;5:2531–45. https://doi.org/10.4155/bio.13.198 .
doi: 10.4155/bio.13.198
Borman P. Distinguishing the analytical method from the analytical procedure to support the USP analytical procedure life cycle paradigm © 2019 The U.S. Pharmacopeial Convention (USP): Pharmacopeial Forum; 2019. p. 45.
Borman P, Campa C, Delpierre G, Hook E, Jackson P, Kelley W, et al. Selection of analytical technology and development of analytical procedures using the analytical target profile. In: Anal Chem [Internet]: American Chemical Society; 2021. https://doi.org/10.1021/acs.analchem.1c03854 .
doi: 10.1021/acs.analchem.1c03854
Medicines & Healthcare Products Regulatory Agency (MHRA). Technical review of MHRA analytical quality by Design Project. 2019.
(MHRA) M& HPRA. MHRA response and strategy for the application of analytical quality by design concepts to pharmacopoeial standards for medicinese [Internet]. 2020. Available from: https://www.gov.uk/government/consultations/consultation-on-the-application-of-analytical-quality-by-design-aqbd-principles-to-pharmacopoeial-standards-for-medicines
Barwick VJ, Ellison SLR. The evaluation of measurement uncertainty from method validation studies. Accredit Qual Assur [Internet]. 2000;5:47–53. https://doi.org/10.1007/s007690050010 .
doi: 10.1007/s007690050010
Barwick VJ, Ellison SLR, Rafferty MJQ, Gill RS. The evaluation of measurement uncertainty from method validation studies Part 2: measurement uncertainty in chemical analysis. In: De Bièvre P, Günzler H, editors. . Berlin, Heidelberg: Springer Berlin Heidelberg; 2003. p. 187–96. https://doi.org/10.1007/978-3-662-05173-3_34 .
doi: 10.1007/978-3-662-05173-3_34
Ceriotti F. Deriving proper measurement uncertainty from Internal Quality Control data: an impossible mission? In: Clin. Biochem: Elsevier Inc.; 2018. p. 37–40.
Separovic L, Saviano AM, Lourenço FR. Using measurement uncertainty to assess the fitness for purpose of an HPLC analytical method in the pharmaceutical industry. Measurement. 2018;119:41–5.
doi: 10.1016/j.measurement.2018.01.048
Ishikawa K, 石川馨, Asian productivity organization. Guide to quality control. Asian Productivity Organization; 1986.
Tague NR. The quality toolbox: ASQ Quality Press; 2005.
Kovacs E, Ermer J, McGregor PL, Nethercote P, LoBrutto R, Martin GP, et al. Stimuli to the revision process: analytical control strategy. 2016;42.
Montgomery DC. Design and analysis of experiments. 10th ed: Wiley; 2019.
Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, Vangdeginste BGM, Massart DL. Guidance for robustness/ruggedness tests in method validation. J Pharm Biomed Anal. 2001:723–53.
Plackett RL, Burman JP. The design of optimum multifactorial experiments. Biometrika. JSTOR. 1946;33:305.
doi: 10.1093/biomet/33.4.305
Box GEP, Wilson KB. On the experimental attainment of optimum conditions. Source J. R. Stat. Soc. Ser. B. 1951.
Borman PJ, Chatfield MJ, Damjanov I, Jackson P. Method ruggedness studies incorporating a risk based approach: a tutorial. Anal Chim Acta [Internet]; 2011;703:101–113. Available from: https://pubmed.ncbi.nlm.nih.gov/21889624
Peraman R, Bhadraya K, Padmanabha RY. Analytical quality by design: a tool for regulatory flexibility and robust analytics. In: Marini R, editor. Int J Anal Chem [Internet]: Hindawi Publishing Corporation; 2015. p. 868727. https://doi.org/10.1155/2015/868727 .
doi: 10.1155/2015/868727
Borman PJ, Schofield TL, Lansky D. Reducing uncertainty of an analytical method through efficient use of replication. Pharm Technol. 2021.
Deidda R, Orlandini S, Hubert P, Hubert C. Risk-based approach for method development in pharmaceutical quality control context: a critical review. J Pharm Biomed Anal. Elsevier. 2018;161:110–21.
doi: 10.1016/j.jpba.2018.07.050
Nethercote P, Ermer J. Quality by design for analytical methods: implications for method validation and transfer. Pharm Technol [Internet]. 2012;36:74–9 Available from: https://www.pharmtech.com/view/quality-design-analytical-methods-implications-method-validation-and-transfer .
Nethercote P, Bornman P, Bennett T, Martin G, McGregor P. Pharmaceutical quality by design | QbD for better method validation and transfer | Pharmaceutical Manufacturing [Internet]. In: Pharm. Manuf; 2010. Available from: https://www.pharmamanufacturing.com/articles/2010/060/ .
Deming SN. Statistics in the laboratory: control charts, Part 1. Am. Lab. 2016.
Deming SN. Statistics in the laboratory: control charts, Part 2. Am. Lab. 2016.
Deng H, Runger G, Tuv E. System monitoring with real-time contrasts. In: J Qual Technol [Internet], vol. 44: Taylor & Francis; 2012. p. 9–27. https://doi.org/10.1080/00224065.2012.11917878 .
doi: 10.1080/00224065.2012.11917878
Wills S. The 21st century laboratory: information technology and health care. Clin Leadersh Manag Rev. United States. 2000;14:289–91.
Ray CA, Ahene AB. Ligand binding assays in the 21st century laboratory-a call for change. In: AAPS J [Internet], vol. 14: Springer US; 2012. p. 377–9. Available from: https://pubmed.ncbi.nlm.nih.gov/22476913 .